LIPHATECH has secured a key position in the market thanks to its unique investment dynamic.

Each year, Liphatech allocates between 12 and 15% of its turnover into the search for innovations. A subsidiary of De Sangosse, whose original shareholding model is a strength, the company has
just opened its very first Fablab dedicated to the design of new equipment. This impressively functional space, like a start-up, is backed by the existing applied research laboratory. Here are 4 encounters to discover in a few lines what makes Liphatech unique on the market.